Search

Competing Interests: BR was the methods chair of the WHO COVID-19 Therapeutics GDG that assessed hydroxychloroquine treatment. TA is a board member of the MAGIC Evidence Ecosystem Foundation, a not-for-profit organisation that provides methodological support to the GDG. JD is the network lead, WHO Health Emergencies chair, and is part of the WHO COVID-19 Therapeutics Steering Committee. LA is a member of the WHO COVID-19 Therapeutics Steering Committee and a scientist and methods lead in the WHO Department of Quality Assurance of Norms and Standards.